학술논문
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial
Document Type
Article
Author
Staden, Ute; Claßen, Martin; Schuster, Antje; Mellies, Uwe; Posselt, Hans-Georg; Wiebel, Matthias; Rietschel, Ernst; Stern, Martin; Teschler, Helmut; Smaczny, Christina; Köhnlein, Thomas; Wienhausen-Wilke, Vera; Claaß, Andreas; Biedermann, Thomas; Dockter, Gerd; Köster, Holger; Hebestreit, Helge; Ballke, Ernst-Hinrich; Heuer, Hans-Eberhard; Kamin, Wolfgang; Küster, Peter; Szczepanski, Rüdiger; Keller, Klaus-Michael; Generlich, Horst; Bresser, Hans-Georg; Kopp, Matthias; Herting, Egbert; Feickert, Hans-Joachim; Hautz, Jürgen; Schilling, Birgit; Meyer, Egbert; Mall, Marcus A; Wiebicke, Wolfram; Tegtmeyer, Friedrich-Karl; Honer, Marguerite; Mosnier-Pudar, Helen; Lenoir, Gérard; Robert, Jean-Jacques; Kessler, Laurence; Weiss, Laurence; Nove-Josserand, Raphaële; Vantyghem, Marie-Christine; Munck, Anne; Wizla, Nathalie; Leroy, Sylvie; Loeuille, Guy-André; Serreau, Raphaël; Aissat, Fawzia; Thalhammer, Gabriela H; Huttegger, Isidor; Eichler, Irmgard; Götz, Manfred; Ballmann, Manfred; Hubert, Dominique; Assael, Baroukh M; Staab, Doris; Hebestreit, Alexandra; Naehrlich, Lutz; Nickolay, Tanja; Prinz, Nicole; Holl, Reinhard W
Source
In The Lancet Diabetes & Endocrinology February 2018 6(2):114-121
Subject
Language
ISSN
2213-8587